HumanBioMonitoring-Schoeters - BioDetection Systems

More documents

Recommendations

Info

The future: The EU Pilot ProjectESBIO recommendations to implementation groupMother-child cohorts– Mothers: 22-50 years old– Children: 6-11 years old• Comparable with CDC data• Ethical aspects• Before onset of puberty– 120 pairs per MS (6000 samples in total)
The future: The EU Pilot ProjectESBIO recommendations to implementation group• Scenario 1 (all countries)– Pb in blood– Cd in urine– MeHg in hair– Cotinine in urine• Scenario 2– Any compound in at least 5 countries (phtalates, PAHs,…)– Scenario 3• Include specific research questions (e.g. ‘omics’)• Use of receptor based assays
Page 2 and 3: Outline• An introduction to human
Page 4 and 5: The causal chain:from exposure to e
Page 6 and 7: A brief introduction to HBMspecific
Page 8 and 9: A brief introduction to HBM• Envi
Page 10 and 11: Evaluating time trendsMean lipid-ad
Page 12 and 13: Relation with health effects
Page 14 and 15: o evaluate the efficacity of policy
Page 16 and 17: European initiatives humanbiomonito
Page 20 and 21: 2 Main types of HBM activities- SUR
Page 22 and 23: wo protocolsASilicacolumnHexane/DEE
Page 24 and 25: Breast milk monitoringblicationCoun
Page 26 and 27: HBM in FlandersFlanders(1998)EU(199
Page 28 and 29: Effect of gender:Marker PCBs (ng/ g
Page 30 and 31: Determinants of CALUX TEQin adolesc
Page 32 and 33: Correlation between CaluxTEQ and to
Page 34 and 35: Study areas:8 study areas in Flande
Page 36 and 37: FLEHS: newborns cord blood (2002-20
Page 38 and 39: HBM in Flanders• Some results-Ris
Page 40 and 41: PitfallsComparison between differen

HumanBioMonitoring-Schoeters - BioDetection Systems

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?